Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder

Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive... ORIGINAL CONTRIBUTION Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial Martin E. Franklin, PhD Context The extant literature on the treatment of pediatric obsessive-compulsive dis- Jeffrey Sapyta, PhD order (OCD) indicates that partial response to serotonin reuptake inhibitors (SRIs) is the norm and that augmentation with short-term OCD-specific cognitive behavior Jennifer B. Freeman, PhD therapy (CBT) may provide additional benefit. Muniya Khanna, PhD Objective To examine the effects of augmenting SRIs with CBT or a brief form of Scott Compton, PhD CBT, instructions in CBT delivered in the context of medication management. Daniel Almirall, PhD Design, Setting, and Participants A 12-week randomized controlled trial con- ducted at 3 academic medical centers between 2004 and 2009, involving 124 pedi- Phoebe Moore, PhD atric outpatients between the ages of 7 and 17 years with OCD as a primary diagnosis Molly Choate-Summers, PhD and a Children’s Yale-Brown Obsessive Compulsive Scale score of 16 or higher de- Abbe Garcia, PhD spite an adequate SRI trial. Interventions Participants were randomly assigned to 1 of 3 treatment strategies Aubrey L. Edson, BA that included 7 sessions over 12 weeks: 42 in the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder

Loading next page...
 
/lp/american-medical-association/cognitive-behavior-therapy-augmentation-of-pharmacotherapy-in-jADH0yVQMz
Publisher
American Medical Association
Copyright
Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2011.1344
pmid
21934055
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL CONTRIBUTION Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial Martin E. Franklin, PhD Context The extant literature on the treatment of pediatric obsessive-compulsive dis- Jeffrey Sapyta, PhD order (OCD) indicates that partial response to serotonin reuptake inhibitors (SRIs) is the norm and that augmentation with short-term OCD-specific cognitive behavior Jennifer B. Freeman, PhD therapy (CBT) may provide additional benefit. Muniya Khanna, PhD Objective To examine the effects of augmenting SRIs with CBT or a brief form of Scott Compton, PhD CBT, instructions in CBT delivered in the context of medication management. Daniel Almirall, PhD Design, Setting, and Participants A 12-week randomized controlled trial con- ducted at 3 academic medical centers between 2004 and 2009, involving 124 pedi- Phoebe Moore, PhD atric outpatients between the ages of 7 and 17 years with OCD as a primary diagnosis Molly Choate-Summers, PhD and a Children’s Yale-Brown Obsessive Compulsive Scale score of 16 or higher de- Abbe Garcia, PhD spite an adequate SRI trial. Interventions Participants were randomly assigned to 1 of 3 treatment strategies Aubrey L. Edson, BA that included 7 sessions over 12 weeks: 42 in the

Journal

JAMAAmerican Medical Association

Published: Sep 21, 2011

References